Product Information

IBANDRONATE SODIUM 150 MG TAB is a generic product labeled by Bionpharma Inc., priced at $2.7472 per EA under NDC 69452037874. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Mar 19, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBANDRONATE SODIUM 150 MG TAB

IBANDRONATE SODIUM
$2.7472per EA

Strength

150 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452037874

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBANDRONATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA078998

FDA Approved

3/19/2012

TE Code

AB

On Market Since

5/26/2023

Pharmacological Classes

Bisphosphonate
Diphosphonates

Price Statistics

The NADAC for IBANDRONATE SODIUM 150 MG TAB has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7472 per EA
All-time high$4.6877 (Dec 13, 2023)
All-time low$2.6751 (Sep 23, 2026)
52-week high$2.9512
52-week low$2.6751
Median price$3.3098
Average price$3.3891
Largest weekly change-37.5% (Nov 20, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

-0.7%

1M

-0.7%

3M

-0.2%

6M

-2.2%

1Y

-6.1%

3Y

-35.5%

5Y

N/A

All

-27.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBANDRONATE SODIUM 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE SODIUM 150 MG TAB, manufactured by Bionpharma Inc., is $2.7472 per EA (NDC 69452037874), effective Nov 18, 2026.

How has the price of IBANDRONATE SODIUM 150 MG TAB changed over time?

Over the history we have for it, the NADAC for IBANDRONATE SODIUM 150 MG TAB has declined 27.3%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for IBANDRONATE SODIUM 150 MG TAB?

Since Oct 11, 2023, the NADAC for IBANDRONATE SODIUM 150 MG TAB has ranged from a low of $2.6751 (Sep 23, 2026) to a high of $4.6877 (Dec 13, 2023), with a median of $3.3098 per EA.

Are there cheaper alternatives to IBANDRONATE SODIUM 150 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBANDRONATE SODIUM 150 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures IBANDRONATE SODIUM 150 MG TAB?

IBANDRONATE SODIUM 150 MG TAB (NDC 69452037874) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.